Delivery Order SPE2DE21D7010-SPE2D625F3STT
- Not listed
- Nuvasive, Inc. was awarded a $26,729.92 fixed-price delivery order for MODULUS spinal medical products by the Defense Logistics Agency Medical Supply Chain on September 8, 2025, with completion scheduled for September 9, 2025. The contract, which carries no set-aside designation, reflects Nuvasive's competitive success in open market procurements for specialized spinal surgical technologies. The award supports the Department of Defense and Defense Health Agency's medical supply requirements...
- Nuvasive, Inc., a leading medical device manufacturer specializing in spinal surgery products and implants, was awarded a delivery order valued at $1,956.60 by the Defense Logistics Agency (DLA) Medical Supply Chain on August 21, 2025. The contract, which is not associated with any set-aside designation, carries a fixed-price structure with economic price adjustment provisions and is scheduled for completion by September 22, 2025. The place of performance is located in San Diego, California,...
- Nuvasive, Inc., a San Diego-based medical device manufacturer specializing in spinal surgery products, was awarded a delivery order valued at $1,681.90 by the Defense Logistics Agency (DLA) Medical Supply Chain on July 24, 2025. This fixed-price contract with economic price adjustment mechanisms is set to be completed by July 25, 2025. The award represents an open market procurement with no set-aside designation, consistent with Nuvasive's established competitive success in federal healthcare...
- Nuvasive, Inc., a San Diego-based medical device manufacturer specializing in spinal surgery products and technologies, was awarded a delivery order valued at $8,533.00 by the Defense Logistics Agency (DLA) Medical Supply Chain on August 14, 2025. This fixed-price delivery order with economic price adjustment mechanism does not utilize any set-aside designation, indicating the contract was awarded through open market competition. The contract is scheduled for completion by August 15, 2025, and...
- Nuvasive, Inc. was awarded a $8,427 fixed-price delivery order by the Defense Logistics Agency (DLA) Medical Supply Chain on August 25, 2025, for spinal medical devices and surgical products. The contract, which utilizes an economic price adjustment mechanism, is scheduled for completion by August 26, 2025, and will be performed in San Diego, California. This delivery order was awarded through open competition with no set-aside designation, reflecting Nuvasive's competitive standing in federal...
- Nuvasive, Inc., a San Diego-based medical device manufacturer specializing in spinal surgery products, was awarded a delivery order valued at $5,189.76 by the Defense Logistics Agency (DLA) Medical Supply Chain on September 2, 2025. The contract, designated as "SMALL INTERLOCK II," represents a fixed-price delivery order with economic price adjustment mechanisms and carries an ultimate completion date of September 22, 2025. The award was made without any set-aside designation,...
- Nuvasive, Inc., a San Diego-based medical device manufacturer specializing in spinal surgery products, received a $3,317.80 fixed-price delivery order from the Defense Logistics Agency (DLA) Medical Supply Chain on September 8, 2025, with an ultimate completion date of September 26, 2025. This contract award carries no set-aside designation and includes economic price adjustment provisions. The award supports the federal government's medical supply chain operations, which fall under the...
- Nuvasive, Inc., a San Diego-based medical device manufacturer specializing in spinal surgery products, received a $1,956.60 fixed-price delivery order from the Defense Logistics Agency (DLA) Medical Supply Chain on September 11, 2025, with an ultimate completion date of October 3, 2025. This contract, awarded without set-aside designation, demonstrates Nuvasive's continued role as a key supplier of advanced spinal medical technologies to federal healthcare agencies. The delivery order utilizes a...
- Nuvasive, Inc. was awarded a $9,368 delivery order by the Defense Logistics Agency (DLA) Medical Supply Chain on August 13, 2025, with an ultimate completion date of September 3, 2025. This fixed-price contract with economic price adjustment mechanisms represents a non-competitive procurement with no set-aside designation. Nuvasive, a San Diego-based medical device company specializing in spinal surgery products and services, will deliver advanced spinal medical technologies, implants, and...
- Nuvasive, Inc. has been awarded a $37,861.56 delivery order by the Defense Logistics Agency's Medical Supply Chain division, a defense-focused federal agency supporting Department of Defense and Veterans Affairs healthcare operations. This fixed-price contract with economic price adjustment mechanisms is scheduled for completion by September 18, 2025, and involves the delivery of specialized spinal medical technologies and surgical equipment to support military and veteran healthcare...
- SPE2DE21D7010Indefinite Delivery Contract
- SPE2DE21D7010-SPE2D625F3STTDelivery Order
Nuvasive, Inc. was awarded a $11,287.94 fixed-price delivery order by the Defense Logistics Agency (DLA) Medical Supply Chain for the MODULUS spinal medical device on September 11, 2025, with completion scheduled for September 12, 2025. The contract, which carries no set-aside designation, reflects Nuvasive's competitive position in open market procurements for specialized spinal medical technologies. The place of performance is located in San Diego, California, where Nuvasive maintains its primary operations as a leading supplier of spinal surgery products, implants, and surgical instruments to federal healthcare agencies. This delivery order represents a continuation of Nuvasive's ongoing relationship with the federal government through the DLA Medical Supply Chain, which procures medical devices for Department of Defense and Department of Veterans Affairs healthcare systems. The contract incorporates an economic price adjustment mechanism, a standard feature in Nuvasive's federal agreements. As the parent company of Transplant Technology Inc.'s Bone Bank Allografts division, Nuvasive maintains substantial procurement vehicles with federal agencies, including an $8 million Blanket Purchase Agreement with the Defense Health Agency through March 2027, enabling streamlined access to its comprehensive spinal medical device portfolio across the military health system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.3k | 9/11/25 |